# FOCALFLEX (CE Mark) Study

Study · id `cardio:ct-nct06271967` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06271967](<https://clinicaltrials.gov/study/NCT06271967>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06271967

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT06271967. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-15 (actual); primary completion 2025-07-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT06271967, source copy `cardio:ctgov-nct06271967-2026-02-05`, retrieved 2026-10-26)
- Started: 2024-08-15 (actual) (ClinicalTrials.gov record NCT06271967, source copy `cardio:ctgov-nct06271967-2026-02-05`, retrieved 2026-10-26)
- Primary completion: 2025-07-09 (actual) (ClinicalTrials.gov record NCT06271967, source copy `cardio:ctgov-nct06271967-2026-02-05`, retrieved 2026-10-26)
- Completion: 2026-01-19 (actual) (ClinicalTrials.gov record NCT06271967, source copy `cardio:ctgov-nct06271967-2026-02-05`, retrieved 2026-10-26)
- Countries: Australia; Austria; Belgium; Czechia; Denmark; France; Germany; Italy; Netherlands; Spain; United Kingdom (ClinicalTrials.gov record NCT06271967, source copy `cardio:ctgov-nct06271967-2026-02-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06271967-2026-02-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: FOCALFLEX (CE Mark) Study
- Condition: Atrial Fibrillation Paroxysmal
- Intervention (Device): TactiFlex™ Ablation Catheter Sensor Enabled™
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 215bcca6d9cee50af979a31bb6024fec43d5dfd5964e96fca3938a2c549cf475
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
